|Year : 2020 | Volume
| Issue : 4 | Page : 164-167
The assessment of hair transplantation outcomes in cicatricial alopecia
C Madura, N Vinay, MR Kusuma, S Harsha, BS Chandrashekar
Department of Dermatosurgery, CUTIS Academy of Cutaneous Sciences, MRCR Layout, Bengaluru, Karnataka, India
|Date of Submission||22-May-2019|
|Date of Acceptance||17-Jul-2020|
|Date of Web Publication||19-Sep-2020|
Dr. C Madura
FRGUHS, Head of Department of Dermatosurgery, CUTIS Academy of Cutaneous Sciences, Bengaluru, Karnataka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Cicatricial alopecia (CA) is scarring alopecia due to a diverse group of disorders which destroy the hair follicle, replace it with scar tissue causing permanent hair loss. Spontaneous regrowth of hair in CA is rarely seen and thus it has a negative impact on the self-esteem of the patient. However, hair transplantation (HT) has emerged as an effective modality of treatment to replace lost hair for cosmetic benefit. Materials and Methods: This was a prospective analysis of patients affected with CA, who underwent HT from January 2015 to December 2017. Demography of patients along with the duration of disease, stability, biopsy, technique of HT, number of grafts, and other procedures done were noted on a pro forma and analyzed. A test patch of HT was done in all primary CA to assess stability and few secondary CA to look for graft uptake. The patients were followed up for a year and the outcomes were graded by patient and a single observer on a 10 point scale as poor, satisfactory, good, and very good at 3, 6, and 12 months. Results: A total of 50 patients with CA underwent follicular unit extraction. Majority of them were males(84%) with a male to female ratio of 5.25:1. Secondary CA was seen in majority(90%) of the study group. Moustache (56%) was the most common site affected, followed by scalp (22%), beard(14%) and eyebrow(8%). Around 38%(12 atrophic scars; 7 hypertrophic scars) underwent fractional CO2 laser/Erbium YAG laser with or without intralesional steroid injections in a stepwise manner prior to HT. Excellent-to-very good outcome was seen in 82% while 18% were lost for follow up. Conclusion: Scarring in CA has a significant effect on quality of life of affected patients. HT when done taking into consideration the stability of disease has good-to-excellent outcomes thus leading to a positive impact on the patient's life.
Keywords: Cicatricial alopecia, hair transplantation, scar hair transplantation
|How to cite this article:|
Madura C, Vinay N, Kusuma M R, Harsha S, Chandrashekar B S. The assessment of hair transplantation outcomes in cicatricial alopecia. Int J Trichol 2020;12:164-7
|How to cite this URL:|
Madura C, Vinay N, Kusuma M R, Harsha S, Chandrashekar B S. The assessment of hair transplantation outcomes in cicatricial alopecia. Int J Trichol [serial online] 2020 [cited 2021 Jun 16];12:164-7. Available from: https://www.ijtrichology.com/text.asp?2020/12/4/164/295410
| Introduction|| |
Cicatricial alopecia (CA) is scarring alopecia due to a diverse group of disorders which destroy the hair follicle, replace it with scar tissue causing permanent hair loss, in otherwise healthy individuals.
CA is classified as primary or secondary. In primary CA, the permanent portion of hair follicle (stem cells of bulge area and infundibulum) is the target of destructive inflammatory process with relative sparing of interfollicular reticular dermis. The causes vary from autoimmune diseases such as lichen planopilaris, frontal fibrosing alopecia, discoid lupus erythematosus, pseudopelade of brocq and folliculitis decalvans. However, in secondary CA, there is destruction of the hair follicle incidental to a non-follicle directed process or external injury, such as trauma, burns, radiation, or severe infections such as tinea capitis.
On the other hand, CA is divided into two groups as “unstable” and “stable” that aids in selection of patient for treatment. Unstable CAs are commonly seen in primary CA with increased recurrence rate and the disease flare intermittently. Stable CAs are secondary to isolated traumas that cause stable scarring in hairy skin regions as in secondary CA.
Spontaneous regrowth of hair in CA is rarely seen and thus disappointing the patient. The current therapeutic regimens aim to slow or inhibit the progression of the disease with local or systemic immunomodulation. However, hair transplantation (HT) has emerged as an effective modality of treatment, to replace the lost hair for cosmetic benefit.
| Materials and Methods|| |
This was a prospective study of 3 years which included patients affected with CA, who underwent HT from January 2015 to December 2017. Institutional ethical committee clearance was taken. The demographic details of the patients along with the duration of disease, site, biopsy in primary CA, type of HT, number of grafts, other procedures done were noted on a pro forma and analyzed. The site, size, thickness, pliability, and stability of scar were assessed. A minimum of 1 year of disease inactivity was taken as stability in primary CA and minimum 6-month duration from onset of scar in secondary CA was confirmed prior to HT. A test patch of HT was done in all primary CAs to assess stability and a few doubtful cases of secondary CA to see the graft uptake. The thickness and pliability of scars was assessed to decide the time of surgery and for adjuvant treatments such as fractional CO2 laser/Intralesional steroid (ILS). A combination of fractional CO2 laser and ILS 10–20 mg/dl or either alone was used to make the scar pliable and reduce the thickness in hypertrophic scar. Based on the size of scar, the number of grafts were calculated with an average density of 20–25/cm2. The donor site was usually occipital, postauricular region for eyebrow scars and beard region in few moustache scars. The procedure is as described in [Box 1]. The patients were followed up for a year and the outcomes were graded by the patient and a single observer on a ten point scale as not satisfied (1–2), good (3–5), very good (6–8), and excellent (9–10) at 3, 6, and 12 months.
HT outcomes according to patient and investigators were analyzed by ANOVA using SPSS software. The data was represented by descriptive statistics using bar diagrams.
| Results|| |
We had a total of 50 patients affected with CA who underwent HT (FUE technique) Majority of the study group were males 42(84%) with a male to female ratio of 5.25:1. The mean age was 29 years.
Majority 45 (90%) of the study group were affected with secondary CA and all five primary CAs were biopsy proven cases. The various types of CA seen in this study are shown in [Table 1]. Average duration of stability of disease was 3.6 years in primary CA. The average duration of scar was 2.2 years in secondary CA. Moustache (56%) was the most common area affected with CA, followed by scalp (22%), beard (14%), and eyebrow (8%) [Table 2]. Around 19 (38%) patients with 12 atrophic scars and 7 hypertrophic scars underwent fractional CO2/erbium YAG laser with or without ILS injections in a stepwise manner prior to HT. The donor area was occipital region of scalp in 29 (58%) patients and grafts were taken from beard region in 21 (42%) subjects. Single session of HT was done in 42(84%) whereas 7 (14%) underwent two sessions and a single patient needed three sessions of HT.
Excellent-to-very good outcome [Figure 1], [Figure 2], [Figure 3], [Figure 4] of HT was seen in 82% patients of CA while 9 (18%) of them were lost to follow-up [Figure 5]. The average number of grafts transplanted were 131 and in 34 (68%) patients implantation was done with stick and place method. Two cases had hypertrophy of the scar post HT. Recurrence was seen in a single case of morphea as the disease deferred stability.
|Figure 1: Frontal fibrosing alopecia (pre and post hair transplantation)|
Click here to view
|Figure 2: Cicatricial alopecia over beard (pre and post hair transplantation)|
Click here to view
|Figure 3: Cicatricial alopecia over eyebrow (pre and post hair transplantation)|
Click here to view
|Figure 4: Cicatricial alopecia over moustache (pre and post hair transplantation)|
Click here to view
|Figure 5: Hair transplantation outcomes according to patient and investigator|
Click here to view
| Discussion|| |
Surgical treatment of stable CA includes HT, artificial hair fixation, primary excision of affected area, flap surgery, or scar reduction with tissue expansion.,, Due to the inflammatory process in primary CA, it needs to be ensured that the disease process has stabilized before HT is attempted. One year of disease stability is generally recommended before proceeding with a surgical modality of treatment. Choice of the treatment depends on the type of CA along with additional interdependent factors such as availability of donor hair, scalp laxity, the patient's healing characteristics, vascular supply, and the location of the scar.,
HT has become popular in recent years as a method of treating hair loss FUE is a less invasive technique for graft production unlike FUT which has a disadvantage of a linear scar with pain and discomfort. FUE is preferred choice in CA especially with large areas of scattered cicatrices in recipient region., We used 0.8–0.9 mm punches for follicular unit graft extraction. Although either stick and place or premade slit technique can be chosen, author preferred premade slits over stick and place method. Premade slits must be slightly larger and deeper in tight fibrosed scar compared to same size of deeper slits in lax scar. If placed superficially, the grafts will be rejected.
CA lesions have poor graft recipient conditions due to reduced blood perfusion. The number of grafted follicles that survive largely depends on the blood supply of the vascular bed. Limited blood supply can increase the rate of infection, ischemia, and necrosis in the recipient area as grafting may additionally cause vascular injury. We have minimized this by using plain lignocaine 2% without adrenaline for local anaesthesia. A study by Kwon et al. showed that pretreatment of the recipient site with CO2 laser improved the vascularity of the recipient bed and also promoted wound healing leading to better graft uptake. The accelerated growth of transplanted hairs may be due to neoangiogenesis and induction of growth factors and cytokines during the wound healing process after laser-induced thermal damage. Around 38% of our patients underwent fractional CO2 and/or intra-lesional steroid injections in a stepwise manner prior to HT especially in patients with slightly hypertrophic scars and all non pliable scars.
HT in scarring alopecia has low graft survival rates (50%), especially in secondary CA compared to nonscarring alopecia (>90%). Higher follicular unit density is not recommended for scar HT and we followed the average density of 20–25 grafts/cm2. If more density needs to be achieved, a second session of HT can be planned after an interval of 8–12 months. The common complications are hypertrophic scars, graft rejection, infection, and corkscrew hair., Two (4%) of our patients developed hypertrophic scar post-HT.
We observed excellent-to-very good results in majority (81.7%) of our patients. This may be due to proper case selection, adequate procedural priming prior to surgery, following surgical tips [Box 2] and use of topical medications such as minoxidil pre- and post-HT. The fact that surgery might induce a relapse should not defer the patient from pursuing HT in CA and deny them their only chance to correct the alopecic defect.
| Conclusion|| |
Stability of CA has to be looked into before proceeding with HT. Good outcomes are seen when other modalities like lasers, intra-lesional steroid injections are done prior to HT. The possibility of reactivation of disease taking place any time after surgery has to be clearly explained. HT when done taking into consideration the stability of the disease and good surgical techniques will give gratifying results, leading to a positive impact on the patient's life.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias. J Am Acad Dermatol 2005;53:1-37.
Tan E, Martinka M, Ball N, Shapiro J. Primary cicatricial alopecias: Clinicopathology of 112 cases. J Am Acad Dermatol 2004;50:25-32.
Sowjanya CL, Rao TN, Guruprasad P, Khopkar U. Morbidity profile of long distance truck drivers in Hyderabad city, India. J Dr NTR Univ Health Sci 2014;3:234-7.
Unger W, Unger R, Wesley C. The surgical treatment of cicatricial alopecia. Dermatol Ther 2008;21:295-311.
Ekelem C, Pham C, Atanaskova Mesinkovska N. A systematic review of the outcome of hair transplantation in primary scarring alopecia. Skin Appendage Disord 2019;5:65-71.
Harries MJ, Sinclair RD, Macdonald-Hull S, Whiting DA, Griffiths CE, Paus R. Management of primary cicatricial alopecias: Options for treatment. Br J Dermatol 2008;159:1-22.
Kutlubay Z, Murat K, Engin B. Hair transplantation in the cicatricial alopecias. Hair Ther Transplant 2013;3:109.
Stough DB 3rd
, Berger RA, Orentreich N. Surgical improvement of cicatricial alopecia of diverse etiology. Arch Dermatol 1968;97:331-4.
Kwon OS, Kim MH, Park SH, Chung JH, Eun HC, Oh JK. Staged hair transplantation in cicatricial alopecia after carbon dioxide laser-assisted scar tissue remodeling. Arch Dermatol 2007;143:457-60.
Callender VD, Lawson CN, Onwudiwe OC. Hair transplantation in the surgical treatment of central centrifugal cicatricial alopecia. Dermatol Surg 2014;40:1125-31.
Dahdah MJ, Iorizzo M. The role of hair restoration surgery in primary cicatricial alopecia. Skin Appendage Disord 2016;2:57-60.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1], [Table 2]